Patents by Inventor Alex DePaoli

Alex DePaoli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090197813
    Abstract: Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.
    Type: Application
    Filed: December 3, 2008
    Publication date: August 6, 2009
    Inventors: Marc B. Garnick, Paul M. Martha, JR., Christopher J. Molineaux, Alex DePaoli
  • Publication number: 20070015714
    Abstract: Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.
    Type: Application
    Filed: January 30, 2006
    Publication date: January 18, 2007
    Applicant: Praecis Pharmaceuticals, Inc.
    Inventors: Marc Garnick, Paul Martha, Christopher Molineaux, Alex DePaoli
  • Patent number: 7109171
    Abstract: Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: September 19, 2006
    Assignee: Praecis Pharmaceuticals Inc.
    Inventors: Marc B. Garnick, Paul M. Martha, Jr., Christopher J. Molineaux, Alex DePaoli
  • Publication number: 20020058035
    Abstract: Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.
    Type: Application
    Filed: February 27, 2001
    Publication date: May 16, 2002
    Inventors: Marc B. Garnick, Paul M. Martha, Christopher J. Molineaux, Alex DePaoli